Endodontic Post-operative Pain Evaluation of Patients After Using Endomethasone N or Endomethasone SP (EndoPOP)

NCT ID: NCT04885686

Last Updated: 2025-04-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-22

Study Completion Date

2022-06-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a post-marketing performance and safety study, designed as a comparative, prospective, multicenter, simple-blind, randomized clinical trial. 300 subjects requiring a primary or a secondary root canal treatment will be enrolled in 2 groups (150 in each group). The aim of the study is to demonstrate the superiority of the hydrocortisone-containing root canal sealer Endomethasone N RCS, compared to the hydrocortisone-free root canal sealer Endomethasone SP RCS, with regard to reduction of the maximum post-operative spontaneous pain during the 7 days following the root canal treatment.

Root canal treatment procedures will be in accordance with the allocation by randomisation of Endomethasone N RCS or Endomethasone SP RCS. The spontaneous and the Masticatory pain will be record at predefined times, a phone call will be done at 48h and a visit will be realized at day 7 (max Day 14).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Root Canal Obturation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Study subject will be randomized in a 1:1 allocation ratio between the 2 treatment groups; the allocation will be stratified by pre-operative pain (3 classes) and center (12 classes).
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
The color of the two powders are not the same. The dentist will not be blinded to the treatment, but the patient will. The study is simple-blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endomethasone N RCS

Endomethasone N RCS is used in combination with gutta percha points for the permanent obturation of root canals.

Group Type EXPERIMENTAL

Endomethasone N RCS

Intervention Type DEVICE

Root canal sealer

Endomethasone SP RCS

Endomethasone SP RCS is used in combination with gutta percha points for the permanent obturation of root canals.

Group Type ACTIVE_COMPARATOR

Endomethasone SP RCS

Intervention Type DEVICE

Root canal sealer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Endomethasone N RCS

Root canal sealer

Intervention Type DEVICE

Endomethasone SP RCS

Root canal sealer

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult male or female (age ≥ 18 years);
* Patient requiring root canal treatment or retreatment;
* Patient who will need a single visit for the root canal therapy, for a mature molar or second premolar, with or without pre-operative pain
* Patient who received information and gave written consent (signed informed consent form);
* Subject affiliated to a health insurance system, or is a beneficiary (art. L.1121-11, Code of Public Health, France).

Exclusion Criteria

* Pulpotomy or pulpectomy performed at a prior visit;
* Tooth with apical calcification (sealer unable to reach the root apex);
* Tooth with suspected root perforation;
* Immature tooth (too wide root apex requiring an apexification);
* Other dental treatment ongoing or scheduled within the study period;
* At least one symptomatic tooth among those that are not included in this study
* Known hypersensitivity to steroids, local anesthetics, or any component of study medical devices;
* Subject using long term anti-inflammatory drugs;
* Use of illicit substances during the 48h before the first visit (cannabis, cocaine…);
* Presence of any significant medical finding or significant history such as uncontrolled systemic diseases that may impact the safety, the interpretation of the results and/or the participation of the subject in the study according to the opinion of the investigator;
* Subject who cannot be contacted in case of emergency (phone number);
* Simultaneous participation in another clinical trial or subject still within the exclusion period of a previous clinical trial;
* Vulnerable subjects (art. L.1121-5 and L.1122-1-2, Code of Public Health, France; art. 66 of the Regulation (EU) 2017/745 on medical devices)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Slb Pharma

OTHER

Sponsor Role collaborator

Septodont

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yves BOUCHER, PU-PH

Role: STUDY_DIRECTOR

APHP

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cabinet dentaire

Agon-Coutainville, , France

Site Status

Cabinet dentaire

Betton, , France

Site Status

Cabinet dentaire

Chartres-de-Bretagne, , France

Site Status

Cabinet Dentaire

Cherbourg, , France

Site Status

Cabinet dentaire

Cherbourg, , France

Site Status

Cabinet dentaire

Dinan, , France

Site Status

Cabinet dentaire

Équeurdreville-Hainneville, , France

Site Status

Cabinet dentaire

Lamballe, , France

Site Status

Centre de santé dentaire Chevaleret

Paris, , France

Site Status

Centre dentaire Flandre

Paris, , France

Site Status

Cabinet dentaire

Pluguffan, , France

Site Status

Cabinet dentaire

Quimper, , France

Site Status

Cabinet dentaire

Rennes, , France

Site Status

Cabinet dentaire

Saint-Aubin-de-Médoc, , France

Site Status

Cabinet dentaire

Tinténiac, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Boucher Y, Abrgall H, Bar V, Basl-Th Bault FO, Cano S, Colombel H, Le Guicher G, Cameli C. Spontaneous and Masticatory Post-endodontic Pain After Using Endomethasone N vs SP Root Canal Sealers: A Randomised Controlled Clinical Trial. Eur Endod J. 2024 Aug 22;9(3):218-230. doi: 10.14744/eej.2024.96977.

Reference Type BACKGROUND
PMID: 38644670 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A00065-36

Identifier Type: OTHER

Identifier Source: secondary_id

EndoPOP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Post-endodontic Pain Survey
NCT04462731 COMPLETED NA
Biodentine Versus White MTA Pulpotomy
NCT01733420 COMPLETED PHASE3